Skip to main content
. 2017 May 8;11:83. doi: 10.3389/fnbeh.2017.00083

Figure 2.

Figure 2

Differential effects of OX2R and dual OX1/2R antagonism on non-rapid eye movement (NREM) and REM sleep in mice. NREM sleep latencies (A,E) and durations (B,F) and REM sleep latencies (C,G) and durations (D,H) after oral dosing with the OX2R antagonist JNJ-42847922 (30 mg/kg) or vehicle (n = 7 animals per condition; left panel) and with the dual OX1/2R antagonist SB-649868 (30 mg/kg) or vehicle (n = 7 animals per condition; right panel) are represented as means (± SEM) and are expressed in minutes. **p < 0.01 and ***p < 0.001 vs. vehicle, based on a paired Student’s t test for NREM and REM sleep latencies or a two-way repeated measures ANOVA (interaction Time × Treatment) followed by a Bonferroni post hoc test for NREM and REM sleep durations.